館藏書目查詢 > 書目資料
借閱次數 :

Europe glucose monitoring system market 2018-2026 [e-book]

  • 點閱:228
  • 評分:0
  • 評論:0
  • 引用:0
  • 轉寄:0


轉寄 列印
第1級人氣樹(0)
人氣指樹
  • 館藏
  • 簡介
  • 作者簡介
  • 推薦序文
  • 收藏(0)
  • 評論(0)
  • 評分(0)
  • 引用(0)

KEY FINDINGS
The Europe Continuous Glucose Monitoring System (CGMS) market is expected to rise from $255.1 million in 2017 to $3412 million by 2026, exhibiting a CAGR of 33.40% over the forecast period of 2018-2026.
And, the Europe Self-Monitoring of Blood Glucose (SMBG) market is expected to rise from $3005.1 million in 2017 to $5873.9 million by 2026, at a CAGR of 7.94% over the forecasted period.

MARKET INSIGHTS
The number of diabetic patients in this region have increased tremendously over the past few years. This, in turn, increased the need for awareness amongst the people about the advanced CGM devices to monitor glucose levels and manage insulin delivery. Also, there was a need for improvement of health infrastructure for the same. Each of the 28 countries in Europe has its own system for approval of distributing and supplying medical devices. The U.K market dominated the European scene in 2017. However, the French market is expected to rise with the highest CAGR over the forecast period. This is due to the French's health infrastructure and services being one of the best in the world.

COMPETITIVE INSIGHTS
Companies like Beurer GmbH, Abbott, Medtronic, Dexcom, Animas, Sanofi, Pfizer, GlaxoSmithKline, and AstraZeneca are leading in this region.[by Global Information]


內容簡介來源:

此功能為會員專屬功能請先登入
此功能為會員專屬功能請先登入
此功能為會員專屬功能請先登入
此功能為會員專屬功能請先登入


本文的引用網址: